Literature DB >> 30057167

Left ventricular ejection fraction for risk stratification in chronic systolic heart failure.

Alberto Aimo1, James L Januzzi2, Giuseppe Vergaro3, Christina Petersen4, Emilio M Pasanisi4, Sabrina Molinaro5, Claudio Passino3, Michele Emdin3.   

Abstract

BACKGROUND: Left ventricular ejection fraction (LVEF) represents the most used measure of cardiac systolic function. Different cut-offs have been proposed to classify patients with systolic dysfunction, and to inform therapy decision-making.
METHODS: Consecutive outpatients with systolic heart failure (HF; LVEF <50%) were prospectively enrolled and underwent a baseline characterization. The prognostic value of LVEF and LVEF cut-offs was made with regards to the prediction of all-cause and cardiovascular death.
RESULTS: Out of 2160 patients, 71% had LVEF <40%, and 61% had ≤35%. Over a 26-month median follow-up (interquartile interval 12-39), patients with LVEF ≤35% (log-rank 31.11 and 59.48, respectively; both p < 0.001) and <40% (log-rank 24.51 and 41.77, respectively; both p < 0.001) had a significantly worse prognosis for all-cause and cardiovascular death. LVEF independently predicted both endpoints in a strong prognostic model including age, sex, ischaemic aetiology, N-terminal fraction of pro-B-type natriuretic peptide, New York Heart Association class III-IV, several comorbidities and therapies. Receiver operating characteristics curves identified LVEF values 32% and 31% as the best cut-offs for the two endpoints. The 40% and lower cut-offs (35%, 32% or 31%) were independent predictors of all-cause and cardiovascular death (p < 0.001 in all cases). The 35% cut-off had a lower Akaike's Information Criterion value than 40%, denoting more accurate risk stratification.
CONCLUSIONS: LVEF is an independent predictor of all-cause and cardiovascular mortality in chronic systolic HF. The 35% LVEF cut-off displays a better combination of sensitivity and specificity than the 40% cut-off for outcome prediction, although both hold independent prognostic value.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cut-off; Heart failure; Left ventricular ejection fraction; Prognosis

Mesh:

Year:  2018        PMID: 30057167     DOI: 10.1016/j.ijcard.2018.07.117

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  miR-182-5p combined with brain-derived neurotrophic factor assists the diagnosis of chronic heart failure and predicts a poor prognosis.

Authors:  Fang Fang; Xiaonan Zhang; Bin Li; Shouyi Gan
Journal:  J Cardiothorac Surg       Date:  2022-04-30       Impact factor: 1.522

2.  Cardiac Index by Transthoracic Echocardiography (CITE) study.

Authors:  Barna Szabó; Eszter Krisztina Marosi; Katarina Vargová; Noémi Nyolczas
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

3.  Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China.

Authors:  Fanqi Meng; Zhihua Zhang; Xiaofeng Hou; Zhiyong Qian; Yao Wang; Yanhong Chen; Yilian Wang; Ye Zhou; Zhen Chen; Xiwen Zhang; Jing Yang; Jinlong Zhang; Jianghong Guo; Kebei Li; Lu Chen; Ruijuan Zhuang; Hai Jiang; Weihua Zhou; Shaowen Tang; Yongyue Wei; Jiangang Zou
Journal:  BMJ Open       Date:  2019-05-16       Impact factor: 2.692

4.  Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same.

Authors:  Lingyu Xu; Joseph J Pagano; Mark J Haykowksy; Justin A Ezekowitz; Gavin Y Oudit; Yoko Mikami; Andrew Howarth; James A White; Jason R B Dyck; Todd Anderson; D Ian Paterson; Richard B Thompson
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-03       Impact factor: 5.364

5.  Biventricular Morphology and Function Reference Values Derived From a Large Sample of Healthy Chinese Adults by Magnetic Resonance Imaging.

Authors:  Zhen Zhang; Qiaozhi Ma; Yiyuan Gao; Lizhen Cao; Chengcheng Zhu; Zhiwei Zhao; Jun Zhao; Linan Zeng; Mingwu Lou; Gerald M Pohost; Kuncheng Li
Journal:  Front Cardiovasc Med       Date:  2021-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.